-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On February 28, Huadong Medicine announced that its wholly-owned subsidiary signed an equity investment agreement with Heidelberg Pharma in Germany and obtained an exclusive license agreement for the company's products
The company, through its wholly-owned subsidiary Huadong Pharmaceutical Investment Holdings (Hong Kong) Co.
Hangzhou Zhongmei Huadong Pharmaceutical Co.
In addition, Zhongmei Huadong will also obtain the exclusive option of Heidelberg Pharma's other two products under development, HDP-102 and HDP-104